Sallam, M., Ababneh, N., Dababseh, D., Bakri, F., & Mahafzah, A. (2020). Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa: Phylogenetic and mutation analysis study. doi:10.1101/2020.08.24.20176792

University of California, Davis

• Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa: Phylogenetic and mutation analysis study
- The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice

medRxiv Papers for COVID-19 Virology

Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa: Phylogenetic and mutation analysis study

Michaud, W. A., Boland, G. M., & Rabi, S. A. (2020). The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers. BioRxiv, 2020.08.25.267500. https://doi.org/10.1101/2020.08.25.267500


The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers

Tian, J., Patel, N., Haupt, R., Zhou, H., Weston, S., Hammond, H., . . . Smith, G. (2020, January 01). SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice. Retrieved August 17, 2020, from https://www.biorxiv.org/content/10.1101/2020.06.29.178509v1

Learn Before

Related